GenePrint(R) 24 System, 400rxn Kits
Closed Pre-Solicitation Posted
- Solicitation number
- 25-002231
- Agency
-
NIH Clinical Center
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH) Clinical Center intends to issue a firm-fixed price Purchase Order to Promega Corporation for GenePrint(R) 24 System, 400rxn Kits, which are critical for conducting engraftment monitoring Chimerism Testing in their clinical laboratory. These specialized kits are used to amplify Short Tandem Repeats (STR) for monitoring donor pluripotent cells in bone marrow and stem cell transplant patients. Promega Corporation is identified as the sole manufacturer and supplier of these proprietary kits, which are essential for patient treatment and care. The acquisition will be conducted under Federal Acquisition Regulation 13.501 for sole source acquisitions. Interested parties capable of providing similar products are invited to submit capability statements by February 20, 2025, at 3pm EST, with the understanding that the government retains sole discretion in determining whether to compete the proposed contract.
The pre-solicitation notice indicates no specific set-aside designation for this contract. The purchase order will cover a six-month base year with two additional twelve-month option years, spanning from March 1, 2025, to September 30, 2027. The total contract period is approximately three years, with Promega Corporation as the intended sole source vendor. The procurement is specifically for the GenePrint 24 System, 400rxn Kits (Product Code: B1874), which will be used by the Department of Laboratory Medicine, Hematology Service at the NIH Clinical Center located in Bethesda, Maryland. The product falls under NAICS Code 325413 for In-Vitro Diagnostic Substance Manufacturing and Product Service Code 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits And Sets. Potential vendors interested in providing alternative solutions must submit their capability statements to Tasha Lowe, Contract Specialist, at lowet2@mail.nih.gov.
Notice text
GenePrint(R) 24 System, 400rxn Kits
- Product Service Code: 6550
- NAICS Code: 325413
- Place of Performance:
National Institutes of Health
Clinical Center
10 Center Drive
Bethesda, MD 20892
POTS: 25-002231
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued, and quotations will not be requested.
The National Institutes of Health, Office of Purchasing and Contracts, on behalf of the Department of Laboratory Medicine, Hematology Service, intends to issue a firm-fixed price Purchase Order to Promega Corporation, located at 2800 Woods Hollow Rd, Fitchburg, Wisconsin 53711-5300. The order will cover a six (6) month base year, with two (2) additional twelve (12) month option years, for the GenePrint® 24 System, 400rxn Kits (Product Code: B1874). Period of Performance: 03/01/2025-09/30/2027.
The Department of Laboratory Medicine, Hematology Service, conducts engraftment monitoring Chimerism Testing in the clinical laboratory for patients who have undergone allogeneic transplants. The GenePrint® 24 System kits are utilized to amplify Short Tandem Repeats (STR) for monitoring the engraftment chimerism of donor pluripotent cells in bone marrow and stem cell transplant patients. The GenePrint® 24 System, 400rxn Kits are the only kits that have been fully validated for this use and can generate the required number of loci for the protocol. Promega Corporation is the sole manufacturer and supplier of these proprietary kits. Without the GenePrint® 24 System, 400rxn kits, patient treatment and care would be negatively impacted.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation 13.501 Special documentation requirements for sole source acquisitions exceeding the Simplified Acquisition Threshold.
Interested Parties:
Interested parties capable of providing the same or similar products or services described in this notice may submit a capability statement outlining their capability to perform the described work. Capability Statements must be received within the time set forth in this synopsis to be considered by the Government. The determination to compete this proposed contract based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Comments:
Comments to this announcement, referencing this posting number on the email subject line, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Tasha Lowe Contract Specialist, lowet2@mail.nih.gov by the due date February 20, 2025, (3pm EST) and time marked in this notice.
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity